Unease grows among US doctors over Indian drug quality

The Baltimore Sun / Reuters, March 19, 2014
Some U.S. doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration. India supplies about 40 percent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada. In recent months, the FDA, citing quality control problems ranging from data manipulation to sanitation, has banned the importation of products from Ranbaxy Laboratories Ltd, Wockhardt Ltd and, most recently, Sun Pharmaceutical Industries Ltd.

MOST POPULAR

" style="font-family:inherit">Physician's Scathing Remarks Humiliate Patient, Cost Hospital
  • Alternative Staffing Arrangements
  • " style="font-family:inherit">The Perils of Cut-and-Paste Documentation
  • Aging Doctors: Time for Mandatory Competency Testing?
  • 7 Years In, Triple Aim Transcends Jargon
  • Alternative Staffing Arrangements
  • CMS Predictive Readmission Models 'Not Very Good'
  • SPONSORED REPORTS
    SPONSORED HEADLINES

    SIGN UP

    FREE e-Newsletters Join the Council Subscribe to HL magazine

    SPONSORSHIP & ADVERTISING

    100 Winners Circle Suite 300
    Brentwood, TN 37027

    800-727-5257

    About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
    © HealthLeaders Media 2014 a division of BLR All rights reserved.